PERRIGO Co plc SEC filings PRGO
PERRIGO Co plc has 1,003 filings in SEC EDGAR's recent list, going back to Mar 7, 2016. Its latest annual report, Form ARS, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 26, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 3, 2026 | — |
| DEFA14A | Additional proxy material | Mar 20, 2026 | — |
| DEF 14A | Proxy statement | Mar 20, 2026 | Apr 30, 2026 |
| DEFA14A | Additional proxy material | Mar 21, 2025 | — |
| DEF 14A | Proxy statement | Mar 21, 2025 | May 1, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 10, 2025 | May 1, 2025 |
| DEFA14A | Additional proxy material | Mar 22, 2024 | — |
| DEF 14A | Proxy statement | Mar 22, 2024 | May 2, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 12, 2024 | May 2, 2024 |
| DEFA14A | Additional proxy material | Mar 24, 2023 | — |
| DEF 14A | Proxy statement | Mar 24, 2023 | — |
| PRE 14A | Preliminary proxy statement | Mar 10, 2023 | — |
| DEFA14A | Additional proxy material | Mar 24, 2022 | — |
| DEF 14A | Proxy statement | Mar 24, 2022 | May 6, 2022 |
| PRE 14A | Preliminary proxy statement | Mar 10, 2022 | May 6, 2022 |
| DEFA14A | Additional proxy material | Apr 1, 2021 | — |
| DEF 14A | Proxy statement | Apr 1, 2021 | May 12, 2021 |
| PRE 14A | Preliminary proxy statement | Mar 19, 2021 | May 12, 2021 |
| DEFA14A | Additional proxy material | Apr 22, 2020 | — |
| DEFA14A | Additional proxy material | Apr 9, 2020 | — |
| DEFA14A | Additional proxy material | Mar 27, 2020 | — |
| DEF 14A | Proxy statement | Mar 27, 2020 | May 6, 2020 |
| PRE 14A | Preliminary proxy statement | Mar 12, 2020 | May 6, 2020 |
| DEFA14A | Additional proxy material | Mar 14, 2019 | — |
| DEF 14A | Proxy statement | Mar 14, 2019 | Apr 26, 2019 |
| PRE 14A | Preliminary proxy statement | Mar 1, 2019 | Apr 26, 2019 |
| DEFA14A | Additional proxy material | Mar 23, 2018 | — |
| DEF 14A | Proxy statement | Mar 23, 2018 | May 4, 2018 |
| PRE 14A | Preliminary proxy statement | Mar 9, 2018 | May 4, 2018 |
| DEFA14A | Additional proxy material | Jun 7, 2017 | — |
| DEF 14A | Proxy statement | Jun 7, 2017 | Jul 20, 2017 |
| PRE 14A | Preliminary proxy statement | May 23, 2017 | Jul 20, 2017 |
| DEFA14A | Additional proxy material | Apr 14, 2016 | — |
| DEFA14A | Additional proxy material | Apr 14, 2016 | — |
| DEFA14A | Additional proxy material | Mar 17, 2016 | — |
| DEF 14A | Proxy statement | Mar 17, 2016 | Apr 26, 2016 |
Showing 36 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PRGO (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- Ireland
- Headquarters
- Dublin 2, Ireland
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1585364
- Former names
- PERRIGO Co Ltd (until Nov 12, 2013)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.